You Searched For: 5-Phenyl-1H-pyrazolo[3,4-c]pyridazin-3-ylamine


24,982  results were found

SearchResultCount:"24982"

Sort Results

List View Easy View

Rate These Search Results

Supplier: Apollo Scientific
Description: 5-Phenyl-1H-pyrazolo[3,4-c]pyridazin-3-ylamine

Supplier: Apollo Scientific
Description: 1-Methyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine

Bürkle single-use powder and liquid funnels

Cleanroom manufactured funnels, a practical and hygienic pouring aid! Also available sterile (10-6). Made of PS, compliant to EU food and FDA regulations.

More info

A truly clean filling aid for your lab

Supplier: Apollo Scientific
Description: 4,6-Dimethyl-1H-pyrazolo[3,4-b]pyridin-3-ylamine

Supplier: Apollo Scientific
Description: 1-Methyl-1H-pyrazolo[3,4-b]pyridin-3-ylamine 97%

Supplier: Apollo Scientific
Description: MAPK/ERK Signalling Pathway

Catalog Number: (APOSOR2650T-250MG)
Supplier: Apollo Scientific
Description: Chemiluminescent with antifilarial & affinity for the adenosine receptor.
UOM: 1 * 250 mg


Supplier: Apollo Scientific
Description: MAPK/ERK Signalling Pathway

Supplier: Thermo Scientific
Description: Apixaban

Supplier: ENZO LIFE SCIENCES AG
Description: Highly potent, ATP-competitive, and specific mTOR kinase inhibitor. Antiproliferative.

New Product

Supplier: Cayman Chemical
Description: Apixaban is an orally bioavailable, selective inhibitor of both free and prothrombinase-bound factor Xa (K<sub>i</sub>s = 0.8 nM).

Supplier: Apollo Scientific
Description: 6-Methyl-4-(trifluoromethyl)-1,6-dihydropyrazolo[3,4-c]pyrazol-3-ylamine 95+%

Supplier: Cayman Chemical
Description: WYE-125132 is an ATP-competitive inhibitor of mTOR (IC<sub>50</sub> = 0,19 nM) that inhibits signaling through both mTORC1 and mTORC2. It is selective for mTOR over phosphatidylinositol 3-kinase isoforms. WYE-125132 is effective against mTORC1 and mTORC2 in diverse cancer models, both <i>in vitro</i> and <i>in vivo</i>. Oral administration of WYE-125132 alone blocks mTOR signaling and prevents tumor growth in breast, lung, renal, and glioma cancer xenografts in mice, while combination therapy with the VEGF-inhibitor bevacizumab causes complete regression of A498 renal carcinoma tumors. In addition to its applications in cancer, WYE-125132 has been used to delineate novel aspects of mTOR signaling.

Catalog Number: (APOSOR305393-1G)
Supplier: Apollo Scientific
Description: 3-Iodo-1H-pyrazolo[3,4-b]pyridine
UOM: 1 * 1 g


Supplier: Apollo Scientific
Description: 6-Bromo-1H-pyrazolo[3,4-b]pyridine

New Product

Supplier: Apollo Scientific
Description: 6-Chloro-1H-pyrazolo[3,4-d]pyrimidine 96%

Catalog Number: (APOSOR30697-1G)
Supplier: Apollo Scientific
Description: 1H-Pyrazolo[3,4-c]pyridine 95+%
UOM: 1 * 1 g


Inquire for Price
Stock for this item is limited, but may be available in a warehouse close to you. Please make sure that you are logged in to the site so that available stock can be displayed. If the call is still displayed and you need assistance, please call us on +353 1 88 22222.
Stock for this item is limited, but may be available in a warehouse close to you. Please make sure that you are logged in to the site so that available stock can be displayed. If the call is still displayed and you need assistance, please call us on +353 1 88 22222
This product is marked as restricted and can only be purchased by approved Shipping Accounts. If you need further assistance, email VWR Regulatory Department at eurega_services@eu.vwr.com
-Additional Documentation May be needed to purchase this item. A VWR representative will contact you if needed.
This product has been blocked by your organisation. Please contact your purchasing department for more information.
The original product is no longer available. The replacement shown is available.
Product(s) marked with this symbol are discontinued - sold till end of stock. Alternatives may be available by searching with the VWR Catalog Number listed above. If you need further assistance, please call VWR Customer Service on +353 1 8822222.
1 - 16 of 24,982
no targeter for Bottom